These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15094367)

  • 1. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
    Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
    Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
    Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
    J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes.
    Lu Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route.
    Hattori Y; Kawakami S; Nakamura K; Yamashita F; Hashida M
    J Pharmacol Exp Ther; 2006 Aug; 318(2):828-34. PubMed ID: 16670348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
    Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M
    Gene Ther; 1999 Jan; 6(1):121-9. PubMed ID: 10341884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
    Hattori Y; Suzuki S; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2005 Nov; 108(2-3):484-95. PubMed ID: 16181701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.
    Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M
    Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
    Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Shimokawa M; Sugita T; Niwa T; Oda A; Akashi M; Tsutsumi Y; Mayumi T; Nakagawa S
    Biochem Biophys Res Commun; 2004 Dec; 325(2):500-5. PubMed ID: 15530420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.
    Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y
    Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
    Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
    J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
    Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
    J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier.
    Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M
    Mol Pharm; 2011 Apr; 8(2):543-54. PubMed ID: 21250746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
    Sheng KC; Kalkanidis M; Pouniotis DS; Esparon S; Tang CK; Apostolopoulos V; Pietersz GA
    Eur J Immunol; 2008 Feb; 38(2):424-36. PubMed ID: 18200633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.
    Carstens MG; Camps MG; Henriksen-Lacey M; Franken K; Ottenhoff TH; Perrie Y; Bouwstra JA; Ossendorp F; Jiskoot W
    Vaccine; 2011 Jun; 29(29-30):4761-70. PubMed ID: 21565240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
    Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
    Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
    J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol consumption modifies dendritic cell antigen presentation in mice.
    Heinz R; Waltenbaugh C
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
    Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
    Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy.
    Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M
    Biomaterials; 2010 Oct; 31(30):7813-26. PubMed ID: 20656348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.